Neurologic aspects of lymphoma and leukemias

Handbook of Clinical Neurology

Volumn 120, Issue , 2014, Pages 1027-1043

  Mccoyd, Matthew ^a   Gruener, Gregory ^a   Foy, Patrick ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

ALL (acute lymphoblastic leukemia); AML (acute myeloid leukemia); APL (acute promyelocytic leukemia); CLL (chronic lymphocytic leukemia); CML (chronic myelogenous leukemia); Hodgkin lymphoma; Leukemia; Lymphoma; Non Hodgkin lymphoma

Indexed keywords

ALL (ACUTE LYMPHOBLASTIC LEUKEMIA); AML (ACUTE MYELOID LEUKEMIA); APL (ACUTE PROMYELOCYTIC LEUKEMIA); ARTICLE; CLL (CHRONIC LYMPHOCYTIC LEUKEMIA); CML (CHRONIC MYELOGENOUS LEUKEMIA); HODGKIN DISEASE; HUMAN; LEUKEMIA; LYMPHOMA; NEUROLOGIC DISEASE; NON-HODGKIN LYMPHOMA;

ALL (ACUTE LYMPHOBLASTIC LEUKEMIA); AML (ACUTE MYELOID LEUKEMIA); APL (ACUTE PROMYELOCYTIC LEUKEMIA); CLL (CHRONIC LYMPHOCYTIC LEUKEMIA); CML (CHRONIC MYELOGENOUS LEUKEMIA); HODGKIN LYMPHOMA; LEUKEMIA; LYMPHOMA; NON-HODGKIN LYMPHOMA;

HUMANS; LEUKEMIA; LYMPHOMA; NERVOUS SYSTEM DISEASES;

EID: 84890809548     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4087-0.00069-3     Document Type: Chapter

References (75)

1. Abel G.A., Friese C.R., Magazu L.S., et al. Delays in referral and diagnosis for chronic hematologic malignances: literature review. Leuk. Lymphoma 2008, 49:1352-1359.
2. Advani R. Optimal therapy of advanced Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2011, 2011:447-450.
3. Ballen K.K., Hasserjian R.P. Case 2-2005: A 39-year-old woman with headache, stiff neck, and photophobia. N. Engl. J. Med. 2005, 352:274-283.
4. Bataille B., Delwail V., Ment E., et al. Primary intracerebral lymphoma: report of 248 cases. J. Neurosurg. 2000, 92:261-266.
5. Bayraktar S., Bayraktar U.D., Ramos J.C., et al. Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors. J Neurooncol 2011, 101:257-265.
6. Berenguer J., Miralles P., Ribera J.M., et al. Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiviral therapy. J. Acquir. Immune Defic. Syndr. 2008, 47:422-428.
7. Bladé J., Dimopoulos M., Rosiňol L., et al. Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations. J. Clin. Oncol. 2009, 28:690-697.
8. Bornkamm G.W. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin. Cancer Biol. 2009, 19:351-365.
9. Bosch E.P., Habermann T.M., Tefferi A. Peripheral neuropathy associated with lymphoma, leukemia and myeloproliferative disorders. Peripheral Neuropathy 2005, 2489-2504. Elsevier Saunders, Philadelphia. 4th edn. P.J. Dyck, P.K. Thomas (Eds.).
10. Briani C., Vitaliani R., Grisold W., et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology 2011, 76:705-710.
11. Chamberlain M.C., Fink J. Neurolymphomatosis: a rare metastatic complication of diffuse large B-cell lymphoma. J. Neurooncol 2009, 95:285-288.
12. Chamberlain M.C., Marc C. Neurologic complications of leukemia. Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and its Treatment 2008, 555-565. Humana Press, Totowa NJ. 2nd edn. D. Schiff, S. Kesari, P.Y. Wen (Eds.).
13. Chamberlain M.C., Nolan C., Abrey L.E. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J. Neurooncol 2005, 75:71-83.
14. Chamberlain M.C., Glantz M., Groves M.D., et al. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin. Oncol. 2009, 36(Supplement 2):S35-S45.
15. Cheng T.M., O'Neill B.P., Sheithauer B.W. Chronic meningitis: the role of meningeal or cortical biopsy. Neurosurg 1994, 34:590-595.
16. Clarke J.L., Perez H.R., Jacks L.M., et al. Leptomeningeal metastases in the MRI era. Neurology 2010, 74:1449-1454.
17. Connors J.M. Clinical manifestations and natural history of Hodgkin's lymphoma. Cancer J. 2009, 15:124-128.
18. da Rocha A.J., da Rocha T.M., da Silva C.J., et al. Cranial vault lymphoma: a systematic review of five patients. J. Neurooncol 2010, 100:9-15.
19. de Leval L., Hasserjian R.P. Diffuse large B-cell lymphomas and Burkitt lymphoma. Hematol Oncol Clin North Am 2009, 23:791-827.
20. Dropcho E.J. The neurologic side effects of chemotherapeutic agents. Continuum 2011, 17:95-112.
21. Enright H., Bond J. Chronic leukemias. Dis. Mon. 2008, 54:242-255.
22. Fain O., Hamidoo M., Laloub P., et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007, 57:1473-1480.
23. Ferreri A.J., Campo E., Seymour J.F., et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the "cutaneous variant. Br. J. Haematol. 2004, 127:173-183.
24. Ferreri A.J.M., Assanelli A., Crocchiolo R., et al. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Hematol. Oncol. 2009, 27:61-70.
25. Fischer L., Martus P., Weller M., et al. Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology 2008, 71:1102-1108.
26. Flanagan E.P., O'Neill B.P., Porter A.B., et al. Primary intramedullary spinal cord lymphoma. Neurology 2011, 77:784-791.
27. Gerstner E.R., Batchelor T.T. Primary central nervous system lymphoma. Arch. Neurol. 2010, 67:291-297.
28. Gieron M.A., Margraf L.R., Korthals J.K., et al. Progressive necrotizing myelopathy associated with leukemia: clinical, pathologic, and MRI correlation. J Child Neurol 1987, 2:44-49.
29. Glass J. Neurologic complications of lymphoma and leukemia. Semin. Oncol. 2006, 33:342-347.
30. Glass J., Melamed M., Chernik N. Malignant cells in cerebrospinal fluid (CSF). The meaning of a positive CSF cytology. Neurology 1979, 29:1369-1375.
31. Goldman J.M., Velo J.V. Chronic myeloid leukemia - advances in biology and new approaches to treatment. N. Engl. J. Med. 2003, 349:1451-1464.
32. Graber J.J., Nolan C.P. Myelopathies in patients with cancer. Arch. Neurol. 2010, 67:298-304.
33. Groves M.D. New strategies in the management of leptomeningeal metastases. Arch. Neurol. 2010, 67:305-312.
34. Haldorsen I.S., Espeland A., Larsson E.M. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011, 32:984-992.
35. Iwamoto F.M., Abrey L.E. Primary dural lymphomas: a review. Neurosurg. Focus 2006, 21:1-5.
36. Jaffe E.S., Harris N.L., Stein H., et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008, 112:4384-4399.
37. Kanai R., Shibuya M., Hata T., et al. A case of "lymphomatosis cerebri" diagnosed in an early phase and treated by whole brain radiation: case report and literature review. J. Neurooncol 2008, 86:83-88.
38. Kantarjian H.M., Smith T., Estey E., et al. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Am. J. Med. 1992, 93:599-604.
39. Katoh N., Matsuda M., Yoshida T., et al. Primary AL amyloid polyneuropathy treated with high-dose melphalan followed by autologous stem cell transplantation. Muscle Nerve 2010, 41:138-143.
40. Kim T., Kim S.J., Kim E., et al. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. Ann. Neurol. 2011, 90:1391-1398.
41. Ko M.W., Dalmau J., Galetta S.L. Neuro-ophthalmologic manifestations of paraneoplastic syndrome. J Neuroophthalmol 2008, 28:58-68.
42. Kolitz J.E. Acute leukemias in adults. Dis. Mon. 2008, 54:226-241.
43. Kumar V., Abbas A.K., Fausto N., et al. Diseases of white blood cells, lymph nodes, spleen and thymus. Robbins and Cotram Pathologic Basis of Disease 2009, 589-638. Saunders Elsevier, Philadelphia. 8th edn. V. Kumar, A.K. Abbas, N. Fausto (Eds.).
44. Kumar S.K., Mikhael J.R., Buadi F.K., et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines. Mayo Clin. Proc. 2009, 84:1095-1110.
45. Küppers R. The biology of Hodgkin's lymphoma. Nat. Rev. Cancer 2009, 9:15.
46. Lin P. Plasma cell myeloma. Hematol Oncol Clin North Am 2009, 23:709-727.
47. Madan S., Greipp P.R. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS). Blood Rev. 2009, 23:257-265.
48. Madan S., Dispenzieri A., Lacy M.Q., et al. Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma. Mayo Clin. Proc. 2010, 85:232-238.
49. Malkani R.G., Tallman M., Gotttardi-Littell N., et al. Bing-Neel syndrome: an illustrative case and a comprehensive review of the literature. J. Neurooncol 2010, 96:301-312.
50. Mughal T.I., Goldman J.M., Mughal S.T. Understanding Leukemias, Lymphomas and Myelomas 2006, Taylor and Francis Group, Boca Faton, FL.
51. Niermeijer J.M.F., Fisher K., Eurelings M., et al. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study. Neurology 2010, 74:406-412.
52. Oberndorfer S., Nussgruber V., Berger O., et al. Stroke in cancer patients: a risk factor analysis. J. Neurooncol 2009, 94:221-226.
53. Ottensmeier C. The classification of lymphomas and leukemias. Chem. Biol. Interact. 2001, 135-136:653-654.
54. Paleologos N.A. Neurologic complications of disorders of white blood cells. Handbook of Clinical Neurology 1993, 339-354. Elsevier Science Publishers, Amsterdam. C.G. Goetz, C.M. Tanner, M.J. Aminoff (Eds.).
55. Perkins A.S., Friedberg J.W. Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program 2008, 2008:341-348.
56. Pochedly C. Neurologic manifestations in acute leukemia: involvement of cranial nerves and hypothalamus. N Y State J Med 1975, 75:715-721.
57. Raab M.A., Podar K., Breitkreutz I., et al. Multiple myeloma. Lancet 2009, 374:324-339.
58. Rajkumar S.V., Dispenzieri A., Kyle R.A. Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, Al amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin. Proc. 2006, 81:693-703.
59. Roglin J., Boer A. Skin manifestations of intravascular lymphoma mimic inflammatory disease of the skin. Br. J. Dermatol. 2007, 157:16-25.
60. Roth P., Korfel A., Martus P., et al. Pathogenesis and management of primary CNS lymphoma. Expert Rev. Anticancer Ther. 2012, 12:623-633.
61. Sanchorawala V. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin. J. Am. Soc. Nephrol. 2006, 1:1331-1341.
62. Shipley J.L., Butera J.N. Acute myelogenous leukemia. Exp. Hematol. 2009, 37:649-658.
63. Steidl C., Lee T., Shah S.P., et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 2010, 362:875-885.
64. Székely G., Miltényi Z., Mezey G., et al. Epidural malignant lymphoma of the spine: collected experiences with epidural malignant lymphoma of the spinal canal and their treatment. Spinal Cord 2008, 46:278-281.
65. Tang Y.Z., Booth T.C., Bhogal P., et al. Imaging of primary central nervous system lymphoma. Clin. Radiol. 2011, 66:768-777.
66. Thirumala R., Ramaswamy M., Chawla S. Diagnosis and management of infectious complications in critically ill patients with cancer. Crit. Care Clin. 2010, 26:59-91.
67. Turesson I., Velez R., Kristinsson S.Y., et al. Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin. Proc. 2010, 85:225-230.
68. Vardiman J.W. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem. Biol. Interact. 2010, 184:16-20.
69. Vardiman J.W., Thiele J., Arber D.A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
70. Walker R.W. Neurologic complications of leukemia. Neurol. Clin. 1991, 9:989-997.
71. Wiernik P.H. Extramedullary manifestations of adult leukemia. Adult Leukemias 2001, 275-306. BC Decker, Hamilton. P.H. Wiernik (Ed.).
72. Wu J.M., Georgy M.F., Burroughs F.H., et al. Lymphoma, leukemia, and pleocytosis in cerebrospinal fluid: is accurate cytopathologic diagnosis possible based on morphology alone. Diagn. Cytopathol. 2009, 27:8204.
73. Yamada S., Nishii R., Oka S., et al. FDG-PET a pivotal imaging modality for diagnosis of stroke-onset intravascular lymphoma. Arch. Neurol. 2010, 67:366-367.
74. Zhou Y., Barlogie B., Shaughnessy J.D. The molecular characterization and clinical management of multiple myeloma in the post-genome era. Leukemia 2009, 23:1941-1956.
75. Zuckerman D., Seliem R., Hochberg E. Intravascular lymphoma: the oncologist's "Great Imitator. Oncologist 2006, 11:496-502.